Merck KGaA (MRK) - Total Assets

Latest as of December 2025: €52.10 Billion EUR ≈ $60.91 Billion USD

Based on the latest financial reports, Merck KGaA (MRK) holds total assets worth €52.10 Billion EUR (≈ $60.91 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Merck KGaA to assess the company's total reinvestment commitment from operating cash flow.

Merck KGaA - Total Assets Trend (2002–2025)

This chart illustrates how Merck KGaA's total assets have evolved over time, based on quarterly financial data. Explore Merck KGaA (MRK) long-term investment share to see how much of total assets are deployed in long-term investments.

Merck KGaA - Asset Composition Analysis

Current Asset Composition (December 2025)

Merck KGaA's total assets of €52.10 Billion consist of 25.4% current assets and 74.6% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	5.3%
Accounts Receivable	€4.77 Billion	9.2%
Inventory	€4.56 Billion	8.8%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€7.66 Billion	14.7%
Goodwill	€17.93 Billion	34.4%

Asset Composition Trend (2002–2025)

This chart illustrates how Merck KGaA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MRK market cap overview.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Merck KGaA's current assets represent 25.4% of total assets in 2025, a decrease from 41.9% in 2002.
Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 4.5% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 24.0% in 2002.
Asset Diversification: The largest asset category is goodwill at 34.4% of total assets.

Merck KGaA Competitors by Total Assets

Key competitors of Merck KGaA based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.84 Billion
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	China	CN¥11.59 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Dermapharm Holding SE XETRA:DMP	Germany	€2.27 Billion
China Animal Husbandry Industry Co Ltd SHG:600195	China	CN¥9.32 Billion
Daewoong Pharma KO:069620	Korea	₩2.26 Trillion

Merck KGaA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.46	1.19	1.00
Quick Ratio	0.96	0.79	0.67
Cash Ratio	0.00	0.00	0.00
Working Capital	€4.19 Billion	€2.16 Billion	€-35.00 Million

Merck KGaA - Advanced Valuation Insights

This section examines the relationship between Merck KGaA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.72
Latest Market Cap to Assets Ratio	0.39
Asset Growth Rate (YoY)	1.0%
Total Assets	€52.10 Billion
Market Capitalization	$20.08 Billion USD

Valuation Analysis

Below Book Valuation: The market values Merck KGaA's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Merck KGaA's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Merck KGaA (2002–2025)

The table below shows the annual total assets of Merck KGaA from 2002 to 2025.

Year	Total Assets	Change
2025-12-31	€52.10 Billion ≈ $60.91 Billion	+1.03%
2024-12-31	€51.57 Billion ≈ $60.29 Billion	+6.33%
2023-12-31	€48.49 Billion ≈ $56.70 Billion	-0.06%
2022-12-31	€48.53 Billion ≈ $56.73 Billion	+6.98%
2021-12-31	€45.36 Billion ≈ $53.03 Billion	+8.53%
2020-12-31	€41.80 Billion ≈ $48.86 Billion	-4.60%
2019-12-31	€43.81 Billion ≈ $51.22 Billion	+18.77%
2018-12-31	€36.89 Billion ≈ $43.13 Billion	+3.56%
2017-12-31	€35.62 Billion ≈ $41.64 Billion	-6.88%
2016-12-31	€38.25 Billion ≈ $44.72 Billion	+0.64%
2015-12-31	€38.01 Billion ≈ $44.43 Billion	+46.12%
2014-12-31	€26.01 Billion ≈ $30.41 Billion	+24.94%
2013-12-31	€20.82 Billion ≈ $24.34 Billion	-3.81%
2012-12-31	€21.64 Billion ≈ $25.30 Billion	-2.16%
2011-12-31	€22.12 Billion ≈ $25.86 Billion	-1.20%
2010-12-31	€22.39 Billion ≈ $26.17 Billion	+33.96%
2009-12-31	€16.71 Billion ≈ $19.54 Billion	+6.83%
2008-12-31	€15.64 Billion ≈ $18.29 Billion	+4.84%
2007-12-31	€14.92 Billion ≈ $17.45 Billion	+84.17%
2006-12-31	€8.10 Billion ≈ $9.47 Billion	+11.29%
2005-12-31	€7.28 Billion ≈ $8.51 Billion	+27.24%
2004-12-31	€5.72 Billion ≈ $6.69 Billion	-18.05%
2003-12-31	€6.98 Billion ≈ $8.16 Billion	-7.04%
2002-12-31	€7.51 Billion ≈ $8.78 Billion	--

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$20.08 Billion

€17.18 Billion EUR

Market Cap Rank

#1294 Global

#285 in Germany

Share Price

€132.90

Change (1 day)

-0.11%

52-Week Range

€102.80 - €139.50

All Time High

€220.61